The White House scrapped plans to hold a meeting today at a Baltimore-based vaccine plant run by Emergent BioSolutions following an exposé from The New York Times. The Biden administration also announced plans to conduct an audit of the Strategic National Stockpile after the publication of the article, which described how the biopharmaceutical company lobbied […]
Multiple reports have said President Trump will announce a $750 million deal with Abbott (NYSE:ABT) for 150 million of its rapid COVID-19 antigen tests. As first reported by Politico before being confirmed by other outlets, a White House official said that Trump will announce the deal tonight, using his speech at the Republican National Convention to […]
(Reuters) – The White House is due to issue an ambitious plan to slow the growing and deadly problem of antibiotic resistance over the next 5 years, 1 that requires massive investments and policy changes from a broad array of U.S. government health agencies, according to a copy of the report reviewed by Reuters.
(Reuters) – The Obama administration on Friday proposed a plan to move most doctors, hospitals and their patients to national standards for handling electronic clinical data by the end of 2017.
The U.S. Department of Health and Human Services (HHS), as part of an effort to propel the $2.9 trillion U.S. healthcare system away from a costly fee-for-service system, released a report draft aimed at establishing an inter operable health information technology system that can be accessed by patients and their healthcare providers.
July 31, 2014 by Arezu Sarvestani
The U.S. Senate yesterday approved an omnibus, $1.012 trillion budget bill that includes the restoration of some $85 million in user fees from medical device and pharmaceutical companies that was held in abeyance by sequestration.
President Barack Obama, who has until midnight tomorrow to sign the measure into law, is expected to quickly add his signature after the 72-26 vote in the Upper Chamber.
The medical device industry this week may have received the strongest argument yet for repealing the 2.3% medical device excise tax.